Literature DB >> 23893246

PI3K in cancer-stroma interactions: bad in seed and ugly in soil.

E Hirsch1, E Ciraolo1, I Franco1, A Ghigo1, M Martini1.   

Abstract

Over the past decade the phosphoinositide-3 kinase (PI3K) signaling pathway emerged as an important player for tumor initiation and growth and, currently, PI3K inhibition constitutes a promising therapeutic approach for solid and hematological tumors. Beside its role in tumor cell evolution, PI3K signaling also provides integral functions for noncancerous cells that reside in healthy tissues surrounding the tumor, also referred as tumor microenvironment (TME). This review will address how PI3K signaling participates to the tumorigenic process and discuss the interaction between tumor cells and the surrounding TME, with particular focus on the role of PI3Ks in tumor-associated immune responses, tumor angiogenesis and metastasis formation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23893246     DOI: 10.1038/onc.2013.265

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

Review 1.  The tumor microenvironment shapes hallmarks of mature B-cell malignancies.

Authors:  K H Shain; W S Dalton; J Tao
Journal:  Oncogene       Date:  2015-02-02       Impact factor: 9.867

2.  Cancer: natural-born killers unleashed.

Authors:  Emilio Hirsch; Francesco Novelli
Journal:  Nature       Date:  2014-06-11       Impact factor: 49.962

Review 3.  PI3K and cancer: lessons, challenges and opportunities.

Authors:  David A Fruman; Christian Rommel
Journal:  Nat Rev Drug Discov       Date:  2014-02       Impact factor: 84.694

4.  The miR-345-3p/PPP2CA signaling axis promotes proliferation and invasion of breast cancer cells.

Authors:  Qian Zeng; Fangfang Jin; Husun Qian; Hongling Chen; Yange Wang; Dian Zhang; Yu Wei; Tingmei Chen; Bianqin Guo; Chengsen Chai
Journal:  Carcinogenesis       Date:  2022-03-24       Impact factor: 4.741

Review 5.  Phosphatidylinositol 3-Kinase: A Link Between Inflammation and Pancreatic Cancer.

Authors:  Chiara Birtolo; Vay Liang W Go; Andrzej Ptasznik; Guido Eibl; Stephen J Pandol
Journal:  Pancreas       Date:  2016-01       Impact factor: 3.327

6.  Prostate epithelial-specific expression of activated PI3K drives stromal collagen production and accumulation.

Authors:  Kyle A Wegner; Brett R Mueller; Christopher J Unterberger; Enrique J Avila; Hannah Ruetten; Anne E Turco; Steven R Oakes; Nicholas M Girardi; Richard B Halberg; Steven M Swanson; Paul C Marker; Chad M Vezina
Journal:  J Pathol       Date:  2019-11-28       Impact factor: 7.996

7.  Activation of the ubiquitin proteasome pathway by silk fibroin modified chitosan nanoparticles in hepatic cancer cells.

Authors:  Ming-Hui Yang; Tze-Wen Chung; Yi-Shan Lu; Yi-Ling Chen; Wan-Chi Tsai; Shiang-Bin Jong; Shyng-Shiou Yuan; Pao-Chi Liao; Po-Chiao Lin; Yu-Chang Tyan
Journal:  Int J Mol Sci       Date:  2015-01-12       Impact factor: 5.923

8.  Chorein addiction in VPS13A overexpressing rhabdomyosarcoma cells.

Authors:  Sabina Honisch; Willi Yu; Guilai Liu; Ioana Alesutan; Syeda T Towhid; Anna Tsapara; Sabine Schleicher; Rupert Handgretinger; Christos Stournaras; Florian Lang
Journal:  Oncotarget       Date:  2015-04-30

Review 9.  Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy.

Authors:  Klaus Okkenhaug; Mariona Graupera; Bart Vanhaesebroeck
Journal:  Cancer Discov       Date:  2016-09-21       Impact factor: 39.397

Review 10.  Targeted therapies for ER+/HER2- metastatic breast cancer.

Authors:  Mutsuko Yamamoto-Ibusuki; Monica Arnedos; Fabrice André
Journal:  BMC Med       Date:  2015-06-09       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.